APA

Espírito Santo V., Passos J., Nzwalo H., Carvalho I., Santos F., Martins C., Salgado L., Silva C. E., Vinhais S., Vilares M., Salgado D. & Nunes S. (20210202). Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience. : Journal of neuro-oncology.

Chicago

Espírito Santo Vera, Passos João, Nzwalo Hipólito, Carvalho Inês, Santos Filipa, Martins Carmo, Salgado Lucília, Silva Conceição E, Vinhais Sofia, Vilares Miguel, Salgado Duarte and Nunes Sofia. 20210202. Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience. : Journal of neuro-oncology.

Harvard

Espírito Santo V., Passos J., Nzwalo H., Carvalho I., Santos F., Martins C., Salgado L., Silva C. E., Vinhais S., Vilares M., Salgado D. and Nunes S. (20210202). Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience. : Journal of neuro-oncology.

MLA

Espírito Santo Vera, Passos João, Nzwalo Hipólito, Carvalho Inês, Santos Filipa, Martins Carmo, Salgado Lucília, Silva Conceição E, Vinhais Sofia, Vilares Miguel, Salgado Duarte and Nunes Sofia. Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience. : Journal of neuro-oncology. 20210202.